FGAM
VNDA icon

Financial Gravity Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Financial Gravity Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$17K Buy
185
+10
+6% +$175 0.01% 827
2021
Q2 		$22K Buy
+175
New +$3.13K 0.01% 790

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Financial Gravity Asset Management's VNDA Position: Q3 2021 in Review

Financial Gravity Asset Management increased its Vanda Pharmaceuticals (VNDA) stake by 5.7% in Q3 2021, buying an estimated $175 and bringing the position to 185 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #827.

Financial Gravity Asset Management first reported a position in VNDA in Q2 2021 and has held it in 2 quarters since. The position peaked at $22K in Q2 2021. 182 funds tracked by Wall St. Rank hold VNDA as of Q3 2021.

  • Financial Gravity Asset Management held 185 shares of Vanda Pharmaceuticals worth $17K as of Q3 2021.
  • Financial Gravity Asset Management bought 10 Vanda Pharmaceuticals shares in Q3 2021, an estimated $175.
  • Vanda Pharmaceuticals made up 0.01% of Financial Gravity Asset Management's portfolio in Q3 2021, its #827 holding.
  • Financial Gravity Asset Management first reported a position in Vanda Pharmaceuticals in Q2 2021 and has held it in 2 quarters since.
  • Financial Gravity Asset Management's Vanda Pharmaceuticals position peaked at $22K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.